Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 355-356, 2003; 10.1373/49.3.355
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Ahsen, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Ahsen, N.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2003;49:355-356.)
© 2003 American Association for Clinical Chemistry, Inc.


Editorials

Labeled Primers for Mutation Scanning: Making Diagnostic Use of the Nucleobase Quenching Effect

Nicolas von Ahsen1

1 Department of Clinical Chemistry, Georg-August University, Robert Koch Strasse 40, 37075 Goettingen, Germany, Fax 49-551-39-12504, E-mail nahsen@gwdg.de

The first 20% of the full text of this article appears below.

The advent of the PCR has revolutionized many molecular biological techniques, including single-nucleotide polymorphism (SNP) detection. Interest in the detection and discovery of human polymorphisms increased further with the complete sequencing of the human genome. The main applications for SNP detection include diagnosis of genetic disease and identification of functional mutations in genes that are of pharmacogenetic importance. The results from testing for somatic mutations remain with a person for a lifetime, and retesting is performed only rarely. To be able to deliver a molecular diagnosis of the highest quality, we must have a sound understanding of the different principles used for the detection of polymorphic DNA.

The clinical laboratory today is equipped with a plethora of assays for the detection of SNPs, and new detection methods continue to be published. Molecular diagnostic assays often make use of the real-time monitoring of hybridization for the detection of base mutations. A common assay set-up uses a fluorescence resonance energy transfer (FRET) probe combination. A 3'-dye-labeled detection probe together with a 5'-dye-labeled and 3'-phosphorylated anchor probe interact by FRET in the hybridized state. In the unhybridized state, no FRET occurs, making this technique applicable to homogeneous single-tube assays. Variations of this theme include the use of exonuclease probes and molecular beacons. Initially it was recommended to avoid attaching the dye to a terminal guanosine residue because quenching was observed (1), but for molecular beacons, a design modification was suggested. Instead of the second dye or quencher, a string of guanosine bases was opposed to the single dye on . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.